PolyPid Ltd. (PYPD): R&D Expense
$23.81M
Year ended 2025-12-31
-5.3%
3-year compound annual growth
+7.0%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $23.81M | +4.4% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $22.81M | +41.3% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $16.15M | -42.3% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $27.99M | -8.4% | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | $30.55M | +80.2% | 2024-03-06, From 2021-01-01 |
| 2020-12-31 | $16.95M | +20.4% | 2023-03-31, From 2020-01-01 |
| 2019-12-31 | $14.08M | +12.2% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $12.55M | n/a | 2021-03-05, From 2018-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| PolyPid Ltd. (PYPD) | 2025-12-31 | $23.81M | +4.4% |
| Picard Medical, Inc. (PMI) | 2025-12-31 | $3.05M | -9.8% |
| Polyrizon Ltd. (PLRZ) | 2025-12-31 | $2.13M | +299.4% |
| Femasys Inc (FEMY) | 2025-12-31 | $7.58M | -7.8% |
| INVO Fertility, Inc. (IVF) | 2024-12-31 | $4.9K | -97.1% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| Vivos Therapeutics, Inc. (VVOS) | 2025-12-31 | $100.0K | 0.0% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $4.39M | -16.6% |
| enVVeno Medical Corp (NVNO) | 2025-12-31 | $9.98M | -18.5% |
Compare PYPD, PMI, PLRZ, FEMY side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗